Prescribing Patterns of Hydroxychloroquine and Corticosteroids Among Lupus Patients After New-onset End-stage Renal Disease.

About one third of patients with lupus nephritis and new onset ESRD received CS monotherapy at high doses. As CS-related complications contribute to hospitalizations and deaths in SLE ESRD, changing these prescribing practices may improve morbidity and mortality outcomes.